MedTech Dive March 13, 2024
The collaborators aim to resolve the clinical, regulatory, coverage and payment questions facing developers of the devices.
Dive Brief:
- Mass General Brigham has created a collaborative community to accelerate the development of implantable brain-computer interface (BCI) devices.
- The group, which Mass General Brigham disclosed Monday, brings BCI experts together with the Food and Drug Administration and other organizations to develop harmonized approaches to the technology.
- The collaborators aim to resolve the clinical, regulatory, coverage and payment questions facing developers of BCIs and thereby try to improve patient access to the technology.
Dive Insight:
BCI is a technology that receives and interprets brain signals and then translates them into commands to carry out a specific action. The technology is...
Today's Sponsors
Today's Sponsor